2-71674156-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001130987.2(DYSF):​c.5785-41C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.835 in 1,591,058 control chromosomes in the GnomAD database, including 558,694 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.77 ( 46340 hom., cov: 31)
Exomes 𝑓: 0.84 ( 512354 hom. )

Consequence

DYSF
NM_001130987.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.675

Publications

12 publications found
Variant links:
Genes affected
DYSF (HGNC:3097): (dysferlin) The protein encoded by this gene belongs to the ferlin family and is a skeletal muscle protein found associated with the sarcolemma. It is involved in muscle contraction and contains C2 domains that play a role in calcium-mediated membrane fusion events, suggesting that it may be involved in membrane regeneration and repair. In addition, the protein encoded by this gene binds caveolin-3, a skeletal muscle membrane protein which is important in the formation of caveolae. Specific mutations in this gene have been shown to cause autosomal recessive limb girdle muscular dystrophy type 2B (LGMD2B) as well as Miyoshi myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2008]
DYSF Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuromuscular disease caused by qualitative or quantitative defects of dysferlin
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • autosomal recessive limb-girdle muscular dystrophy type 2B
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • distal myopathy with anterior tibial onset
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital myopathy, Paradas type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Miyoshi myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 2-71674156-C-T is Benign according to our data. Variant chr2-71674156-C-T is described in ClinVar as Benign. ClinVar VariationId is 259082.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.855 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DYSFNM_001130987.2 linkc.5785-41C>T intron_variant Intron 51 of 55 ENST00000410020.8 NP_001124459.1
DYSFNM_003494.4 linkc.5668-41C>T intron_variant Intron 50 of 54 ENST00000258104.8 NP_003485.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DYSFENST00000410020.8 linkc.5785-41C>T intron_variant Intron 51 of 55 1 NM_001130987.2 ENSP00000386881.3
DYSFENST00000258104.8 linkc.5668-41C>T intron_variant Intron 50 of 54 1 NM_003494.4 ENSP00000258104.3

Frequencies

GnomAD3 genomes
AF:
0.773
AC:
117510
AN:
151952
Hom.:
46341
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.611
Gnomad AMI
AF:
0.830
Gnomad AMR
AF:
0.766
Gnomad ASJ
AF:
0.792
Gnomad EAS
AF:
0.699
Gnomad SAS
AF:
0.792
Gnomad FIN
AF:
0.869
Gnomad MID
AF:
0.839
Gnomad NFE
AF:
0.861
Gnomad OTH
AF:
0.787
GnomAD2 exomes
AF:
0.806
AC:
201112
AN:
249436
AF XY:
0.813
show subpopulations
Gnomad AFR exome
AF:
0.608
Gnomad AMR exome
AF:
0.745
Gnomad ASJ exome
AF:
0.806
Gnomad EAS exome
AF:
0.712
Gnomad FIN exome
AF:
0.865
Gnomad NFE exome
AF:
0.859
Gnomad OTH exome
AF:
0.811
GnomAD4 exome
AF:
0.842
AC:
1210948
AN:
1438988
Hom.:
512354
Cov.:
25
AF XY:
0.840
AC XY:
602764
AN XY:
717338
show subpopulations
African (AFR)
AF:
0.597
AC:
19629
AN:
32902
American (AMR)
AF:
0.748
AC:
33310
AN:
44504
Ashkenazi Jewish (ASJ)
AF:
0.805
AC:
20897
AN:
25948
East Asian (EAS)
AF:
0.650
AC:
25714
AN:
39560
South Asian (SAS)
AF:
0.795
AC:
68153
AN:
85690
European-Finnish (FIN)
AF:
0.863
AC:
46038
AN:
53352
Middle Eastern (MID)
AF:
0.815
AC:
4414
AN:
5414
European-Non Finnish (NFE)
AF:
0.864
AC:
943809
AN:
1092014
Other (OTH)
AF:
0.822
AC:
48984
AN:
59604
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
10122
20245
30367
40490
50612
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20650
41300
61950
82600
103250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.773
AC:
117539
AN:
152070
Hom.:
46340
Cov.:
31
AF XY:
0.773
AC XY:
57461
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.610
AC:
25298
AN:
41440
American (AMR)
AF:
0.766
AC:
11716
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.792
AC:
2747
AN:
3468
East Asian (EAS)
AF:
0.698
AC:
3602
AN:
5160
South Asian (SAS)
AF:
0.792
AC:
3813
AN:
4812
European-Finnish (FIN)
AF:
0.869
AC:
9211
AN:
10594
Middle Eastern (MID)
AF:
0.827
AC:
243
AN:
294
European-Non Finnish (NFE)
AF:
0.861
AC:
58501
AN:
67984
Other (OTH)
AF:
0.783
AC:
1653
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1299
2598
3896
5195
6494
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
866
1732
2598
3464
4330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.828
Hom.:
92050
Bravo
AF:
0.759
Asia WGS
AF:
0.710
AC:
2468
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Distal myopathy with anterior tibial onset Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive limb-girdle muscular dystrophy type 2B Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Miyoshi muscular dystrophy 1 Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
5.6
DANN
Benign
0.60
PhyloP100
-0.68
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2559081; hg19: chr2-71901286; API